Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novartis Sandoz unit completes Fougera purchase
Yahoo/AP
Monday, July 23, 2012 - 9:18am
tags:
Sandoz, Novartis, Fougera, M&A
A Busy Week For Bio-Pharma Earnings, Drug Approvals
TheStreet.com
Monday, July 23, 2012 - 9:15am
tags:
drug approvals, earnings, Amylin, InterMune, Human Genome Sciences, GSK, Bristol-Myers Squibb, Questcor, BiogenIdec, Alexion, Regeneron, Eli Lilly, Amarin, Horizon Pharma, Celgene, Amgen, Gilead, Alkermes, United Therapeutics, Roche, Sanofi, Merck, AstraZeneca, Salix, Progenics Pharmaceuticals
Questcor Pharmaceuticals Is A Buy Before Earnings
Seeking Alpha
Monday, July 23, 2012 - 9:06am
tags:
Questcor Pharmaceuticals, earnings
Pharma IPOs Are Good Medicine
TheStreet.com
Monday, July 23, 2012 - 9:05am
tags:
IPOs, Clovis Oncology, Supernus Pharmaceuticals, NewLink Genetics, Horizon Pharma, Globus Medical, Hyperion Therapeutics
InterMune: Weak Esbriet Sales But In-Line Pricing
TheStreet.com
Monday, July 23, 2012 - 9:01am
tags:
earnings, InterMune
BrainStorm Cell reports outstanding ALS interim clinical trial results
The Fly on the Wall
Monday, July 23, 2012 - 9:00am
tags:
BrainStorm Cell Therapeutics, ALS, NurOwn
3 Pharma Companies Expected To Demonstrate Significant Growth During The Second Quarter
Seeking Alpha
Monday, July 23, 2012 - 8:58am
tags:
BioDelivery Sciences, Spectrum Pharmaceuticals, Questcor
ImmunoCellular Therapeutics: Explaining The Benefits Of A Multiple Antigen Targeting Approach
Seeking Alpha
Monday, July 23, 2012 - 8:56am
tags:
ImmunoCellular Therapeutics, glioblastoma, ICT-107
Bayer says Nexavar-Tarceva trial unsuccessful
Reuters
Monday, July 23, 2012 - 8:55am
tags:
Nexavar, Tarceva, Bayer, liver cancer, ONYX Pharmaceuticals
Can Array BioPharma's Breakout Run Hold Or Continue?
Seeking Alpha
Monday, July 23, 2012 - 8:53am
tags:
Array Biopharma, Amgen
Breast Cancer Halted By Novartis Drug From Easter Island
Bloomberg
Monday, July 23, 2012 - 8:50am
tags:
Novartis, Afinitor, breast cancer
Elder Pharma forms new dedicated division to strengthen product reach and elevate brands
Equity Bulls
Sunday, July 22, 2012 - 8:53am
tags:
Elder Pharmaceuticals
Pfizer stops Teva selling generic Lyrica
Globes, Israel
Sunday, July 22, 2012 - 8:42am
tags:
Pfizer, Lyrica, generics
Double Disappointment! Has This Pharma Lost Its Touch?
Motley Fool
Sunday, July 22, 2012 - 8:35am
tags:
Bristol-Myers Squibb
Has This Obesity-Drug Maker Gained Too Much Weight?
Motley Fool
Sunday, July 22, 2012 - 8:33am
tags:
Vivus, Qsymia, weight loss, obesity
Amicus Therapeutics' CEO Hosts GSK Expanded Fabry Collaboration Call (Transcript)
Seeking Alpha
Sunday, July 22, 2012 - 8:32am
tags:
GSK, Amicus Therapeutics
Vivus Tips the Second Scale of Hope for Slimming Obesity
Wall St Cheat Street
Sunday, July 22, 2012 - 8:30am
tags:
Vivus, Qsymia, obesity, weight loss
Biotech Industry Showing Impressive Growth -- Galena Biopharma and Synta Pharmaceuticals Soaring
Business Review USA
Saturday, July 21, 2012 - 12:12pm
tags:
Galena Biopharma, Synta Pharmaceuticals
Takeda and Millennium Announce Positive CHMP Opinion for Conditional Approval of Adcetris in Europe
Enhanced Online News
Saturday, July 21, 2012 - 12:11pm
tags:
Adcetris, Takeda, Millennium
Taro board rejects Sun Pharma offer for total control
Hindu BusinessLine, India
Saturday, July 21, 2012 - 12:07pm
tags:
Taro, Sun Pharma, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.